Home > PJ (current issue) > Reviews | Search

The Pharmaceutical Journal
Vol 274 No 7331 p25
1/8 January 2005

Books

Useful reference source which pulls together much of the current literature and best practice

Osteoporosis in focus’, by Niall Ferguson. Pp xv+229. Price £29.95. London: Pharmaceutical Press; 2004. ISBN 0 85369 483 4


Osteoporosis is a major health issue today in countries with an increasing ageing population. Many different health care professionals are involved in the care of patients with osteoporosis, and access to up-to-date knowledge about the disease has often been difficult. This book is intended as a reference source for the many people who treat patients with (or at risk of developing) osteoporosis; it pulls together much of the current literature and best practice.

The book is structured in a logical format. Discussion of the physiology and epidemiology of the disease, and definition of the different categories of osteoporosis form the first chapter. Risk factors and conditions which predispose to osteoporosis are clearly described. There is much discussion of the prevention of osteoporosis. Benefits in reducing modifiable risk factors are debated at length throughout the book.

Radiological techniques used currently for diagnosis and monitoring of the condition, and important biochemical markers are explained, together with the limitations regarding their use. Photographs showing radiological images of osteoporotic bone would have added a useful extra dimension to this chapter.

Pharmaceutical prevention and treatment of the disease is covered in detail over several chapters. Information about the drugs is comprehensive; the advantages and disadvantages of different therapies are discussed fully. Potential future drugs are also discussed; but there is no mention of teriparatide (recombinant parathyroid hormone), which is now licensed for treatment of established osteoporosis in post-menopausal women. Information is given regarding drugs which can induce osteoporosis and those which can contribute to falls (and hence possible fractures).

The concluding chapters debate the future management of osteoporosis; screening programmes and the pharmaceutical care of osteoporotic patients is discussed in depth.

This book is a useful reference source which should be of benefit to health care professionals with an interest in osteoporosis. The chapters are well-referenced, allowing areas of specific interest to be explored in more detail.


Elizabeth Thomas

Back to Top

Elizabeth Thomas is senior pharmacist, clinical trials and rheumatology at University Hospital Birmingham NHS Trust


©The Pharmaceutical Journal